Skip to main content

News Archive

News Archive - All Stories

Early Retina Cell Changes in Glaucoma Identified

February 11, 2015

To better understand these cellular changes and how they influence the progression and severity of glaucoma, researchers at University of California, San Diego School of Medicine and Shiley Eye Institute turned to a mouse model of the disease. Their study, published Feb. 10 in The Journal of Neuroscience, reveals how some types of retinal ganglion cells alter their structures within seven days of elevated eye pressure, while others do not.

UC San Diego/SDSC Study Advances Brain Cancer Research

February 11, 2015

Researchers at the San Diego Supercomputer Center (SDSC), Moores Cancer Center, and Department of Neurosciences at the University of California, San Diego, have shown for the first time a pyramid hierarchical network of “coherent gene modules” that regulate glioblastoma genes, involved in a highly aggressive form of brain cancer.

SDSC Participates in CalWater Extreme Precipitation Project

February 11, 2015

The San Diego Supercomputer Center (SDSC) and the University of California, San Diego, is providing data management, visualization and modeling resources, and expertise to a two-month wintertime field campaign to study “atmospheric rivers” and particles of dust, smoke, sea spray, and organic materials called aerosols along the western U.S. coast to better understand variability in the region’s water supply, flood and drought hazards, infrastructure requirements, and optimal reservoir operations.

Newly Named Shiley Eye Institute Projects Bigger, Bolder Vision

February 11, 2015

Reflecting its emergence as a regional hub for unparalleled clinical care, research, education and community service, the UC San Diego Shiley Eye Center has been renamed the UC San Diego Donald P. and Darlene V. Shiley Eye Institute, encompassing the Shiley Eye Center, the Anne F. and Abraham Ratner Children’s Eye Center, the Hamilton Glaucoma Center and the Joan and Irwin Jacobs Retina Center.

Building Mini-Brains to Study Disorders Caused by HIV and Meth Use

February 10, 2015

A University of California, San Diego School of Medicine project involving the creation of miniature models of the human brain – developed with stem cells – to study neurological disorders caused by HIV and methamphetamine use has been named one of five recipients of the 2015 Avant-Garde Award for HIV/AIDS Research from the National Institute on Drug Abuse (NIDA).

National Grant Funds Project to Address Safety and Wellbeing of Older Drivers

February 9, 2015

Researchers at the UC San Diego School of Medicine will share a $12 million grant with peer institutions across the United States to better understand the factors that influence the safety of older drivers, such as physical and cognitive functions, medical conditions, medications and adoption of vehicle technologies.

MRI Technique Developed for Nonalcoholic Fatty Liver Disease in Children

February 5, 2015

Between 5 and 8 million children in the United States have nonalcoholic fatty liver disease (NAFLD), yet most cases go undiagnosed. To help address this issue, researchers at UC San Diego School of Medicine have developed a new magnetic resonance imaging (MRI)-based technique to help clinicians and researchers better detect and evaluate NAFLD in children.

Princeton Review Names UC San Diego Top University for Return-on-Investment

February 5, 2015

UC San Diego has earned top recognition in The Princeton Review’s new rankings for the return-on-investment the campus offers to students. UC San Diego is ranked the nation’s 31st best college for students seeking great academics, outstanding career preparation and generous financial aid. The campus is also named a great value, taking the No. 21 spot as the best U.S. college for students who are not eligible for financial aid.

Patient Advocates and Big Pharma Fund Nation’s First Angioedema Treatment Center

February 5, 2015

It is rare for an “orphan” disease (typically a condition that affects fewer than 200,000 people nationwide) to have a specific center dedicated to providing treatment and research. And it is even more unusual for big pharmaceutical companies to invest in an endowment to fund this type of center. Fortunately, the US Hereditary Angioedema Association (HAEA), a nonprofit patient advocacy organization, along with four pharmaceutical companies—Shire Human Genetics Therapies Inc., ViroPharma Incorporated (which merged with Shire), Dyax Corp. and CSL Bering—pledged a total of $4.6 million to help make the US HAEA Angioedema Center at UC San Diego Health System a reality. A number of individuals, including those with the disease, also provided private support.

First Satellite to View Earth from Deep Space Set for Launch

February 5, 2015

A satellite that will be positioned between Earth and the sun to measure the solar energy reflected back to space by Earth as well as the infrared radiation emitted by the planet is scheduled for launch Feb. 8 or 9. Researchers at Scripps Institution of Oceanography proposed the scientific objectives and began designing the instrument payload for the mission nearly 17 years ago.
Category navigation with Social links